When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

President-elect Donald Trump has chosen two prominent men to lead health-related affairs in his administration, Mehmet Oz, MD, and Robert Kennedy, Jr. While the two leaders will be leading health ...

Weight-loss drug stocks were catapulted into the spotlight in 2024, creating a lucrative, groundbreaking, and high-stakes ...

Both tapped by President-elect Donald Trump for high-profile government roles, Mehmet Oz, MD, and Robert F. Kennedy, Jr. have ...

From childhood malaria vaccines to record-breaking solar panels to the discovery of a lost ancient city, this tumultuous year ...

Health Care Health Care   The Big Story MAHA leaders heading for clash over GLP-1 drugs Two of President-elect Trump’s top ...

Pharmaceuticals for the development of a potential. “We are pleased to partner with Amylyx to advance GLP-1 receptor antagonism research. This collaboration and development agreement is an example of ...

This year saw several advancements across medicine, space technology, and AI that extend our knowledge in consequential ways.

Amylyx Pharmaceuticals Inc ( (AMLX) ) has provided an update.

Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial ...